fosciclopirox
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 15, 2018 (NCT03348514)
Timeline
Indications
Mechanism of action
NOTCH1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04956042 | Phase 1/Phase 2 (Phase 2) | Aug 27, 2021 | CicloMed LLC |
| NCT04525131 | Phase 2 | Nov 25, 2020 | CicloMed LLC, University of Kansas |
| NCT04608045 | Phase 1 | May 1, 2019 | CicloMed LLC, University of Kansas |
| NCT03348514 | Phase 1 | Jan 15, 2018 | CicloMed LLC, CMed Technologies Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CicloMed LLC | For profit | 4 | 4 | 2 | 2018 |
| University of Kansas | Academic/Hospital | 2 | 0 | 2 | 2019 |
| CMed Technologies Inc. | For profit | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1